HOMOLOGY MODELING OF TRANSCRIPTIONAL REGULATORS: UNVEILING MECHANISMS AND DRUG DESIGN STRATEGIES IN LIVER CANCER RESEARCH

Authors

  • Dr Sarwat Abbasi
  • Dr. Nighat Parveen
  • Dr. Sumaira Javed
  • Dr. Sofia Jadoon
  • Dr. Uzma Faryal
  • Dr. Farnaz Iqbal Khan

DOI:

https://doi.org/10.53555/vdpdzk52

Abstract

Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related morbidity and mortality worldwide. Transcriptional regulators play a key role in the development and progression of HCC by modulating critical pathways involved in cell cycle regulation, apoptosis, and metastasis. Understanding the structure and function of these regulatory proteins is essential for identifying potential therapeutic targets and developing novel treatments.

Objective: The aim of this study was to perform sequence and structural analysis of a hypothetical transcriptional regulator protein in HCC using homology modeling techniques. By constructing a reliable three-dimensional model of the protein, we sought to better understand its structural properties, potential interactions, and its role in liver cancer progression.

Materials: Homology modeling was conducted using Modeller 9.10. The sequence of the target protein was aligned with a suitable template identified through a BLAST search against the Protein Data Bank (PDB). The template with the highest sequence identity and best alignment was selected for model construction. Structural reliability was assessed using RMSD (Root Mean Square Deviation) and Ramachandran plot analysis to evaluate the quality and accuracy of the generated model.

Conclusion: The homology model of the transcriptional regulator in HCC revealed important structural insights that can contribute to understanding its role in liver cancer pathogenesis. The modeling approach showed that the protein’s structural integrity was satisfactory, with accurate phi and psi dihedral angles. Despite its potential, homology modeling has limitations, particularly when template quality is suboptimal. Validation through experimental data is necessary to confirm the model’s relevance for drug design and functional studies in HCC.

Author Biographies

  • Dr Sarwat Abbasi

    MBBS, MPhil, Assistant Professor of Biochemistry, Ayub Medical College, Abbottabad, Pakistan

  • Dr. Nighat Parveen

    MBBS, MPhil, Assistant Professor of Physiology, Abbottabad International Medical College, Abbottabad, Pakistan

  • Dr. Sumaira Javed

    Associate Professor, Anatomy department, Ayub medical college, Abbottabad, Pakistan

  • Dr. Sofia Jadoon

    MBBS, MPhil, Associate Professor, Anatomy, Abbottabad International Medical College, Abbottabad, Pakistan

  • Dr. Uzma Faryal

    MBBS, MPhil, Professor of Biochemistry, Department of Biochemistry, Women Medical and Dental College, Abbottabad, Pakistan

  • Dr. Farnaz Iqbal Khan

    Lecturer Anatomy, Abbottabad International Medical College, Abbottabad, Pakistan

References

1. Sayiner M, Golabi P, Younossi ZM. Disease burden of hepatocellular carcinoma: a global perspective. Digestive diseases and sciences. 2019 Apr 15;64:910-7.

2. Hou Y, Hu S, Li X, He W, Wu G. Amino acid metabolism in the liver: nutritional and physiological significance. Amino Acids in Nutrition and Health: Amino acids in systems function and health. 2020:21-37.

3. Tachmatzidi EC, Galanopoulou O, Talianidis I. Transcription control of liver development. Cells. 2021 Aug 8;10(8):2026.

4. Baghel VS, Shinde S, Dixit V, Vishvakarma NK, Tiwari AK, Tiwari S, Shukla D. Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options. InTheranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022 Jan 1 (pp. 337-355). Academic Press.

5. Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences. 2019 Jan 15;76:99-128.

6. He J. Effects of IKK/NF-κB signaling in MYC-driven liver tumorigenesis (Doctoral dissertation, Universität Ulm).

7. Lim LJ, Wong SY, Huang F, Lim S, Chong SS, Ooi LL, Kon OL, Lee CG. Roles and regulation of long noncoding RNAs in hepatocellular carcinoma. Cancer Research. 2019 Oct 15;79(20):5131-9.

8. Choudhary HB, Mandlik SK, Mandlik DS. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology. 2023 Jun 6;14(3):46.

9. Yang YM, Kim SY, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. InSeminars in liver disease 2019 Feb (Vol. 39, No. 01, pp. 026-042). Thieme Medical Publishers.

10. Chahal V, Nirwan S, Kakkar R. Combined approach of homology modeling, molecular dynamics, and docking: computer-aided drug discovery. Physical Sciences Reviews. 2019 Oct 25;4(10):20190066.

11. Baluapuri A, Wolf E, Eilers M. Target gene-independent functions of MYC oncoproteins. Nature Reviews Molecular Cell Biology. 2020 May;21(5):255-67.

12. İşcan AÇ. Systems Biomedicine Approaches in Renal Cell Carcinomas to Identify Subtype-specific Molecular Signatures and Potential Therapeutics (Doctoral dissertation, Marmara Universitesi (Turkey)).

13. Szilveszter RM, Muntean M, Florea A. Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview. Biomolecules. 2024 Jun 4;14(6):656.

14. Kessel A, Ben-Tal N. Introduction to proteins: structure, function, and motion. Chapman and Hall/CRC; 2018 Mar 22.

15. Idrees S, Nadeem S, Kanwal S, Ehsan B, Yousaf A, Nadeem S, Rajoka MI. In silico sequence analysis, homology modeling and function annotation of Ocimum basilicum hypothetical protein G1CT28_OCIBA. International Journal Bioautomation. 2012;16(2):111.

Downloads

Published

2024-01-22

How to Cite

Dr Sarwat Abbasi, Dr. Nighat Parveen, Dr. Sumaira Javed, Dr. Sofia Jadoon, Dr. Uzma Faryal, & Dr. Farnaz Iqbal Khan. (2024). HOMOLOGY MODELING OF TRANSCRIPTIONAL REGULATORS: UNVEILING MECHANISMS AND DRUG DESIGN STRATEGIES IN LIVER CANCER RESEARCH. Journal of Population Therapeutics and Clinical Pharmacology, 32(1), 983-988. https://doi.org/10.53555/vdpdzk52
More Citation Formats

Issue

Section

Articles

How to Cite

Dr Sarwat Abbasi, Dr. Nighat Parveen, Dr. Sumaira Javed, Dr. Sofia Jadoon, Dr. Uzma Faryal, & Dr. Farnaz Iqbal Khan. (2024). HOMOLOGY MODELING OF TRANSCRIPTIONAL REGULATORS: UNVEILING MECHANISMS AND DRUG DESIGN STRATEGIES IN LIVER CANCER RESEARCH. Journal of Population Therapeutics and Clinical Pharmacology, 32(1), 983-988. https://doi.org/10.53555/vdpdzk52

Most read articles by the same author(s)